- Home
- RENB vs NAMI Comparison
RENB vs NAMI Comparison
Compare RENB & NAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- NAMI
- Stock Information
- Founded
- RENB 2011
- NAMI 2014
- Country
- RENB United States
- NAMI China
- Employees
- RENB N/A
- NAMI N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- NAMI
- Sector
- RENB Health Care
- NAMI
- Exchange
- RENB Nasdaq
- NAMI NYSE
- Market Cap
- RENB 279.3M
- NAMI 286.0M
- IPO Year
- RENB N/A
- NAMI 2024
- Fundamental
- Price
- RENB $1.67
- NAMI $4.73
- Analyst Decision
- RENB
- NAMI
- Analyst Count
- RENB 0
- NAMI 0
- Target Price
- RENB N/A
- NAMI N/A
- AVG Volume (30 Days)
- RENB 1.5M
- NAMI 440.9K
- Earning Date
- RENB 02-12-2025
- NAMI 02-11-2025
- Dividend Yield
- RENB N/A
- NAMI N/A
- EPS Growth
- RENB N/A
- NAMI N/A
- EPS
- RENB N/A
- NAMI 0.37
- Revenue
- RENB N/A
- NAMI $56,127,097.00
- Revenue This Year
- RENB N/A
- NAMI N/A
- Revenue Next Year
- RENB N/A
- NAMI N/A
- P/E Ratio
- RENB N/A
- NAMI $12.27
- Revenue Growth
- RENB N/A
- NAMI 64.40
- 52 Week Low
- RENB $0.40
- NAMI $3.75
- 52 Week High
- RENB $5.25
- NAMI $7.75
- Technical
- Relative Strength Index (RSI)
- RENB 64.47
- NAMI N/A
- Support Level
- RENB $1.50
- NAMI N/A
- Resistance Level
- RENB $2.04
- NAMI N/A
- Average True Range (ATR)
- RENB 0.34
- NAMI 0.00
- MACD
- RENB 0.00
- NAMI 0.00
- Stochastic Oscillator
- RENB 68.38
- NAMI 0.00
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About NAMI JINXIN TECHNOLOGY HOLDING COMPANY SPONSORED ADS EACH REP 18 ORD SHS
Jinxin Technology Holding Co is a company which operates through its subsidiaries are principally engaged in provision of digital textbook subscription services in the People's Republic of China. The Company generates revenue by selling its content to hardware manufacturers in China whereby they are allowed to install the Company's digital educational content on the manufacturers' devices for sale to end users.